About Lind Partners
At Lind, we understand the challenges faced by management teams of growing companies.
By upholding our mission to be a responsible investor and a reliable financial partner, we have built a reputation as a leading provider of growth capital to the small- and mid-cap sector.
The Lind Partners is a New York-based alternative asset management firm that manages a family
of institutional investment funds focused on small- and mid-cap publicly traded companies with an emphasis on Australia, Canada and the United Kingdom. Since 2009, the core team at Lind has worked on over 35 direct investments with a total transaction value in excess of $385 million.
The Lind Senior Team
Jeffrey L. Easton | Founder, Managing Director
Jeffrey L. Easton is the founder and Managing Director of The Lind Partners. He has over 15 years of experience in the funds management business. In 2009, Jeff co-founded SpringTree Global Investors, a New York-based institutional investment firm. He has since been instrumental in developing and implementing an institutional investment platform that has made investments across a wide range of industries including biotechnology, healthcare, oil & gas, coal and other natural resources. Prior to SpringTree, Jeff was the founding partner of Broad Street Capital, a boutique hedge fund designed to take advantage of market volatility while investing in small capitalization companies. Prior to that, he was an independent trader in small to micro-cap equities utilizing the Broadway Trading’s platform. While there, he also financed, mentored and directed his own successful trading group. Jeff is an active angel investor in several successful ventures including Axioma and Kickstarter and has been featured in several media publications including a cover story in the Wall Street Journal. He currently sits on the board of Metal Storm Limited and graduated from Syracuse University in 1995 with a Bachelor of Science degree in Finance.
Phillip Valliere | Partner, Managing Director
Phillip Valliere is a Partner and Managing Director at The Lind Partners. He joined Lind at its inception and has been instrumental in the firm’s development and leads Lind’s investment efforts in Canada. Mr. Valliere has over 17 years of asset management and investment banking experience in New York City and, over the past three years, he has been involved with institutional funds that completed more than 35 investments into junior public companies in mining, oil & gas, biotech and clean-tech, totaling more than $385 million in transaction value. Prior to Lind, Mr. Valliere was an Executive Vice President & Director of Business Development at SpringTree Global Investors, LLC, a New York-based institutional investment firm. Previously, he was a Vice President at a New York-based hedge fund which he helped grow from $25 million to $2.2 billion AUM, at its peak. During his tenure, he founded and led the oil & gas group and was instrumental in completing more than $450 million of investments into growth-oriented companies in the US, Canada and the UK by utilizing public equity, private equity, convertible debt, mezzanine, senior debt and subordinated debt. Prior to, he worked his way up the ranks from Analyst to Senior Associate in the Corporate Finance Group at Benedetto, Gartland & Co., a New York-based boutique investment bank, founded in 1988, focused on M&A, corporate advisory and private capital fundraising. During his tenure, he was mentored by some of Wall Street’s brightest investment bankers from Kidder Peabody and Dean Witter and executed more than $1.5 billion of transactions involving small-cap, middle-market and Fortune 500 companies, including Monsanto, Merck KGaA, Corning, Dominion Resources, Omnicom, Kohlberg & Co, American Health Properties, ARV Assisted Living and Donna Karan. Mr. Valliere received a B.S. in Business Administration (Concentration in Finance) from the University of New Hampshire in 1995 and attended Yonsei University in Seoul, South Korea as part of his undergraduate studies.
Arlene Brownstein | Chief Operating Officer
Ms. Brownstein began her industry career in May 1986 when she joined Goldman Sachs & Co. She was associated with Goldman for over 9 years, until September 1995. From September 1995 until December 1998, Ms. Brownstein, while pursuing her PhD in mathematics education, was a Research Assistant/Teaching Fellow at New York University. From September 1996 until December 1998, she was an Adjunct Instructor of statistics and mathematics at the Parsons School of Design. In November 1996 Ms. Brownstein joined Oscar Capital Management, LLC, an asset management firm where she served as that company’s Director of Operations. When Oscar Capital Management was acquired by Neuberger Berman, one of the largest fund management groups in the U.S., in November 2001, Ms. Brownstein became an Operations Director at Neuberger Berman, LLC, an investment adviser and securities broker-dealer. From March 2005 until July 2009, she was the Chief Operating Officer and Chief Financial Officer at SkyBridge Capital, an alternative asset management firm, and President and Chief Financial Officer of its affiliated Broker Dealer, Hastings Capital Group. She served as the Chief Operating Officer of SpringTree Global Investors, LLC from January 2010 until joining Lind. Ms. Brownstein holds a Bachelor of Science Degree in Applied Mathematics and Statistics. She also holds a Master’s Degree in Arts (Mathematics Education) from New York University, which she earned in June 1994.
Martin Rogers | Senior Advisor
Martin Rogers is an Australian National and a recent addition to the Lind Partners team. Prior to joining Lind, for five years Mr. Rogers was the Managing Director & Chief Executive Officer of Prima BioMed Ltd (ASX:PRR, NASDAQ:PBMD), a leading Australian biotechnology company working towards commercialising CVac ovarian cancer vaccine. During Mr. Roger’s tenure, Prima grew from AU$2 million to nearly AU$400 million market cap. Mr Rogers has experience in all aspects of financial, strategic and operational management and has raised over $100m in equity. He has been both an investor and senior executive in a private funded advisory business in the science and biotechnology sectors, where he was instrumental in significantly increasing the value of those investments. Mr Rogers also holds a number of not-for-profit roles and is on the management committee of the National Breast Cancer Foundation and a Council Member at the University of Sydney Physics Foundation and International Science School. He has previously been involved in the origination of a number of new business concepts and the establishment of internal ventures and external partnerships, including finance concept origination in the corporate banking sector for institutions such as Macquarie Bank.
Philosophy & Approach
At Lind, we have an entrepreneurial culture that embraces and encourages creativity while preserving our core values of integrity and disciplined investing.
We strive to work with and invest in dedicated, competent and passionate management teams that have the potential of achieving significant milestones and creating value for all shareholders. Lind’s investment team focuses on a broad range of industries, including natural resources (bulk commodities, precious metals and oil & gas), biotechnology, sustainable and alternative energy, and other growth sectors.
Our investment strategy, as well as our ability to assist companies in growing and creating value, are built upon our disciplined focus on fundamental and qualitative factors combined with sound portfolio management practices.
The success of Lind’s institutional investment platform, to date, is a reflection of our commitment to responsible investing for ourselves, our investors, and our investee companies.
The materials and information on this website are for information purposes only and do not constitute an offer to sell or a solicitation of an offer to purchase any share/interest in any investment vehicles.
Limitation of Liability
While Lind uses reasonable efforts to include accurate and current information on this web site, errors or omissions may occur. Lind makes no warranties or representations as to the accuracy of the information contained on this web site. To the full extent permitted by law, none of Lind or any of its members, or any members, directors, managers, officers, employees, advisers, counsel, equity holders, members, agents or other affiliates of any of the foregoing, or any party involved in creating, producing, or delivering this web site, shall be liable for any direct, incidental, consequential, indirect, or punitive damages that result, or arise, from or in connection with, or are related to the use of, or the inability to use, this web site or the content thereof.
Lind assumes no responsibility, and shall not be liable for, any damages to, or viruses that may infect, your computer equipment or other property due to, in connection with, related to, or arising from, your access to, use of, or browsing in, this web site or your downloading or otherwise using of any materials, data, text, images, video, or audio from this web site.
Use of Materials
Except as otherwise permitted by Lind, no materials from this web site may be copied, reproduced, republished, uploaded, posted, transmitted or distributed in any way. You may download material displayed on this web site for non-commercial, personal use only, provided you also retain all copyright and other proprietary notices contained on the materials. You may not distribute, modify, transmit, reuse, report or use any content of this web site for public or commercial purposes without Lind's prior written permission.
Trademarks and Copyrights
All trademarks, service marks, trade names, logos, icons and other content on or of this web site remain the property of Lind. Nothing contained on the web site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use any trademark displayed on this web site without the prior written permission of Lind or such third party that may own the trademarks displayed on this web site. You may not use the trademarks displayed on this web site, or any other content on this web.